2024
Tackling the excesses of pharmaceutical marketing and promotion
Gupta R, Ramachandran R, Ross J. Tackling the excesses of pharmaceutical marketing and promotion. The BMJ 2024, 385: e076797. PMID: 38772671, DOI: 10.1136/bmj-2023-076797.Peer-Reviewed Original Research
2013
Direct-to-Consumer Television Advertising: Time to Turn Off the Tube?
Ross JS, Kravitz RL. Direct-to-Consumer Television Advertising: Time to Turn Off the Tube? Journal Of General Internal Medicine 2013, 28: 862-864. PMID: 23539285, PMCID: PMC3682047, DOI: 10.1007/s11606-013-2424-2.Commentaries, Editorials and Letters
2011
Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines and Content for Safe Prescribing
Korenstein D, Keyhani S, Mendelson A, Ross JS. Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines and Content for Safe Prescribing. PLOS ONE 2011, 6: e23336. PMID: 21858076, PMCID: PMC3157354, DOI: 10.1371/journal.pone.0023336.Peer-Reviewed Original ResearchConceptsSafe prescribingPharmaceutical advertisementsCross-sectional analysisFDA guidelinesAdherence ratesCounter medicationsMedian 2Inclusion criteriaDisease awarenessCurrent FDA guidelinesDrug AdministrationPrescribingPharmaceutical advertisingSerious riskUnique advertisementsAdherenceDrug namesPublic healthStudy limitationsEfficacy informationGuideline itemsMedical journalsGuidelinesFDARisk
2009
Relationships with the drug industry: More regulation, greater transparency
Krumholz HM, Ross JS. Relationships with the drug industry: More regulation, greater transparency. The BMJ 2009, 338: b211. PMID: 19193612, DOI: 10.1136/bmj.b211.Commentaries, Editorials and Letters
2008
Pharmaceutical Industry Marketing: Understanding Its Impact on Women’s Health
Sufrin CB, Ross JS. Pharmaceutical Industry Marketing: Understanding Its Impact on Women’s Health. Obstetrical & Gynecological Survey 2008, 63: 585-596. PMID: 18713478, DOI: 10.1097/ogx.0b013e31817f1585.Commentaries, Editorials and LettersConceptsWomen's healthOral contraceptive pillsEvidence-based careHealth carePremenstrual dysphoric disorderPharmaceutical marketingContraceptive pillsDysphoric disorderModern health carePhysician behaviorCytology techniqueConsumer advertisingCarePatientsHealthPhysiciansSubstantial evidenceSignificant involvementPractice of medicineDrugsDiscussion of guidelinesProphylaxisProfessional organizationsPillsWomen